Use access key #2 to skip to page content.
$43.56 1.11 (2.61%)
5/16/2008 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar SESAMEnow (94.61) Submitted: 10/06/07 2:38 PM : Outperform Start Price: $50.40 AZN Score: -5.38

Growth is the new name of the game. Drugs are the old name of the game. AZN is both

Report this Post Replies: 1 | Reply

Avatar tommycarstensen (96.73) Submitted: 2/23/08 8:23 AM

Recs: 0 | Rec This

What is your oppinion about the acquisition of MedImmune? I personally think $15.6 bln was a lot to pay for revenue of less than $2 bln per year.

Report this Post Reply

Featured Broker Partners